Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Annette, Gaida"'
Autor:
Susann Cattepoel, Annette Gaida, Alain Kropf, Marc W Nolte, Reinhard Bolli, Sylvia M Miescher
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161826 (2016)
In relation to the recent trials of Intravenous Immunoglobulin (IVIG) in Alzheimer's Disease (AD) it was demonstrated that different IgG preparations contain varying amounts of natural anti-amyloid β (Aβ) antibodies as measured by ELISA. We therefo
Externí odkaz:
https://doaj.org/article/b43db3f3b2db41c39fbf2a3f39025a45
Autor:
Olivier Dietz, Sebastian Rusch, Françoise Brand, Esther Mundwiler-Pachlatko, Annette Gaida, Till Voss, Hans-Peter Beck
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103272 (2014)
Survival and virulence of the human malaria parasite Plasmodium falciparum during the blood stage of infection critically depend on extensive host cell refurbishments mediated through export of numerous parasite proteins into the host cell. The paras
Externí odkaz:
https://doaj.org/article/8c60295cd75345d49254eb0fc1f67ebb
Autor:
Susann Cattepoel, Alexander Schaub, Miriam Ender, Annette Gaida, Alain Kropf, Ursula Guggisberg, Marc W Nolte, Louis Fabri, Paul A Adlard, David I Finkelstein, Reinhard Bolli, Sylvia M Miescher
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63162 (2013)
Intravenous Immunoglobulin (IVIG) has been proposed as a potential therapeutic for Alzheimer's disease (AD) and its efficacy is currently being tested in mild-to-moderate AD. Earlier studies reported the presence of anti-amyloid beta (Aβ) antibodies
Externí odkaz:
https://doaj.org/article/088171df589246178f0026ae2d98411a
Autor:
Annette Gaida, Marion M Becker, Christoph D Schmid, Tobias Bühlmann, Edward J Louis, Hans-Peter Beck
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17782 (2011)
One of the major virulence factors of the malaria causing parasite is the Plasmodium falciparum encoded erythrocyte membrane protein 1 (PfEMP1). It is translocated to It the membrane of infected erythrocytes and expressed from approximately 60 var ge
Externí odkaz:
https://doaj.org/article/26282bcf0e984b7aa47dd7227a2dfdea
Autor:
Annette Gaida, Nicole Spiegl, Alphonse Hubsch, Martin Imboden, Adriano Marques Antunes, Brigitte Zurbriggen, Simon Gerber, Sandra Wymann, Ibrahim El Menyawi
Publikováno v:
Biodrugs
Background Hemolysis, a rare but potentially serious complication of intravenous immunoglobulin (IVIG) therapy, is associated with the presence of antibodies to blood groups A and B (isoagglutinins) in the IVIG product. An immunoaffinity chromatograp
Autor:
Martin Imboden, Liane Hoefferer, Adriano Marques Antunes, Annette Gaida, Isabelle Glauser, Brigitte Siani, Ibrahim El Menyawi, Reinhard Bolli, Katharina Willimann, Eleonora Widmer, Sandra Wymann, Martin O. Spycher
Publikováno v:
Transfusion. 55:S117-S121
BACKGROUND The passive transfer of antibodies specific to blood groups A and B (also called isoagglutinins) contained in immunoglobulin (Ig)G products for intravenous administration (IVIG) is believed to be largely responsible for rare but sometimes
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0161826 (2016)
PLoS ONE, Vol 11, Iss 8, p e0161826 (2016)
In relation to the recent trials of Intravenous Immunoglobulin (IVIG) in Alzheimer's Disease (AD) it was demonstrated that different IgG preparations contain varying amounts of natural anti-amyloid β (Aβ) antibodies as measured by ELISA. We therefo
Autor:
Liane, Hoefferer, Isabelle, Glauser, Annette, Gaida, Katharina, Willimann, Adriano, Marques Antunes, Brigitte, Siani, Sandra, Wymann, Eleonora, Widmer, Ibrahim, El Menyawi, Reinhard, Bolli, Martin, Spycher, Martin, Imboden
Publikováno v:
Transfusion. 55
The passive transfer of antibodies specific to blood groups A and B (also called isoagglutinins) contained in immunoglobulin (Ig)G products for intravenous administration (IVIG) is believed to be largely responsible for rare but sometimes serious IVI
Autor:
Alexander Schaub, Reinhard Bolli, David Finkelstein, Marc W. Nolte, Ursula Guggisberg, Miriam Ender, Sylvia Miescher, Paul A. Adlard, Louis Fabri, Susann Cattepoel, Alain Kropf, Annette Gaida
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 5, p e63162 (2013)
PLoS ONE, Vol 8, Iss 5, p e63162 (2013)
Intravenous Immunoglobulin (IVIG) has been proposed as a potential therapeutic for Alzheimer's disease (AD) and its efficacy is currently being tested in mild-to-moderate AD. Earlier studies reported the presence of anti-amyloid beta (Aβ) antibodies
Autor:
A. Adriano Marques, Thomas Roten, Alphonse Hubsch, Nicole Spiegl, Sandra Wymann, Annette Gaida, Eleonora Widmer, Ibrahim El Menyawi
Publikováno v:
Journal of Allergy and Clinical Immunology. 137:AB81